Hims & Hers Health, Inc. HIMS
3 trading plans running, 33 Form 144 notices for $18.9M
10-Q, 10-K and Form 144What HIMS's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Plans adopted or ended
Trading plans · XBRL, 10-Q and 10-K
From Mar 4, 2025 to Sep 8, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.
| Insider | What | Date | Reported in |
|---|---|---|---|
| Andrew Dudum Director and Chief Executive Officer |
Adopted 10b5-1 plan | Sep 1, 2026 | 10-Q Nov 9, 2026 |
| Irene Becklund Former Chief Accounting Officer(2) |
Ended 10b5-1 plan | Aug 12, 2026 | 10-Q Nov 9, 2026 |
| Soleil Boughton Chief Legal Officer |
Ended 10b5-1 plan | May 21, 2026 | 10-Q Aug 10, 2026 |
| Deborah Autor Director and Chief Policy Officer |
Ended 10b5-1 plan | May 20, 2026 | 10-Q Aug 10, 2026 |
| Oluyemi Okupe Chief Financial Officer |
Adopted 10b5-1 plan | May 20, 2026 | 10-Q Aug 10, 2026 |
| Michael Chi Chief Operating Officer |
Adopted 10b5-1 plan | Dec 1, 2025 | 10-K Feb 23, 2026 |
| Mohamed Elshenawy Chief Technology Officer |
Adopted 10b5-1 plan | Dec 1, 2025 | 10-K Feb 23, 2026 |
| Soleil Boughton Chief Legal Officer |
Adopted 10b5-1 plan | Nov 18, 2025 | 10-K Feb 23, 2026 |
| Andrew Dudum Chief Executive Officer |
Ended 10b5-1 plan | Nov 14, 2025 | 10-K Feb 23, 2026 |
| Patrick H. Carroll, M.D. Chief Medical Officer and Director |
Ended 10b5-1 plan | Nov 14, 2025 | 10-Q Aug 4, 2025 |
| Irene Becklund Chief Accounting Officer |
Adopted 10b5-1 plan | Nov 5, 2025 | 10-K Feb 23, 2026 |
| Deborah Autor Director |
Adopted 10b5-1 plan | Aug 11, 2025 | 10-Q Nov 3, 2025 |
| Oluyemi Okupe Chief Financial Officer |
Adopted 10b5-1 plan | May 21, 2025 | 10-Q Aug 4, 2025 |
| Patrick H. Carroll, M.D. Chief Medical Officer and Director |
Adopted 10b5-1 plan | May 19, 2025 | 10-Q Aug 4, 2025 |
| Mike Chi Chief Commercial Officer |
Adopted 10b5-1 plan | Mar 4, 2025 | 10-Q May 5, 2025 |
| Melissa Baird Chief Operating Officer |
Adopted 10b5-1 plan | Nov 26, 2024 | 10-K Feb 24, 2025 |
| Patrick H. Carroll, M.D. Chief Medical Officer and Director |
Adopted 10b5-1 plan | Nov 8, 2024 | 10-K Feb 24, 2025 |
| Andrew Dudum Chief Executive Officer |
Adopted 10b5-1 plan | Aug 28, 2024 | 10-Q Nov 4, 2024 |
| Soleil Boughton Chief Legal Officer |
Adopted 10b5-1 plan | Aug 28, 2024 | 10-Q Nov 4, 2024 |
| Irene Becklund SVP, Controller |
Adopted 10b5-1 plan | Aug 7, 2024 | 10-Q Nov 4, 2024 |
| Oluyemi Okupe Chief Financial Officer |
Ended 10b5-1 plan | May 31, 2024 | 10-Q Aug 5, 2024 |
| Melissa Baird Chief Operating Officer |
Adopted 10b5-1 plan | May 30, 2024 | 10-Q Aug 5, 2024 |
| Mike Chi Chief Commercial Officer |
Adopted 10b5-1 plan | Mar 1, 2024 | 10-Q May 6, 2024 |
| Michael Chi Chief Marketing Officer |
Ended 10b5-1 plan | Dec 15, 2023 | 10-K Feb 26, 2024 |
| Lynne Chou O’Keefe Director |
Adopted 10b5-1 plan | Dec 12, 2023 | 10-K Feb 26, 2024 |
| Andrew Dudum Chief Executive Officer |
Adopted 10b5-1 plan | Nov 29, 2023 | 10-K Feb 26, 2024 |
| Melissa Baird Chief Operating Officer |
Adopted 10b5-1 plan | Nov 21, 2023 | 10-K Feb 26, 2024 |
| Irene Becklund SVP, Controller |
Adopted 10b5-1 plan | Sep 11, 2023 | 10-Q Nov 6, 2023 |
| Soleil Boughton CLO |
Adopted 10b5-1 plan | Sep 8, 2023 | 10-Q Nov 6, 2023 |
| Lynne Chou O’Keefe, Director | Adopted 10b5-1 plan | May 15, 2023 | 10-Q Aug 7, 2023 |
| Michael Chi, CMO | Adopted 10b5-1 plan | May 11, 2023 | 10-Q Aug 7, 2023 |
| Yemi Okupe, CFO | Ended other arrangement | May 10, 2023 | 10-Q Aug 7, 2023 |
| Melissa Baird Chief Operating Officer |
Adopted plan | – | 10-Q Aug 5, 2024 |
Show the other 25 plans
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 8, 2023.
Notices of planned sales
Form 144 · Form 144 XML, SEC
What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).
| Filed | Seller | Shares | Value |
|---|---|---|---|
| Oct 28, 2026 | Boughton Soleil Officer |
3,462 | $96K |
| Oct 14, 2026 | Boughton Soleil Officer |
3,461 | $101K |
| Oct 1, 2026 | Okupe Oluyemi Officer |
2,000 | $59K |
| Sep 30, 2026 | Boughton Soleil Officer |
3,461 | $101K |
| Sep 22, 2026 | Okupe Oluyemi Officer |
29,277 | $877K |
| Sep 17, 2026 | Okupe Oluyemi Officer |
12,313 | $355K |
| Sep 16, 2026 | Boughton Soleil Officer |
6,236 | $174K |
| Sep 15, 2026 | Elshenawy Mohamed Officer |
7,954 | $226K |
| Sep 15, 2026 | Chi Michael Officer |
14,027 | $398K |
| Sep 2, 2026 | Boughton Soleil Officer |
3,458 | $98K |
| Aug 19, 2026 | Boughton Soleil Officer |
25,111 | $692K |
| Aug 18, 2026 | Autor Deborah M. Officer, Director |
16,773 | $467K |
| Jul 22, 2026 | Pendarvis Christiane Former Director |
3,500 | $113K |
| Jul 6, 2026 | Oluyemi Okupe Officer |
28,652 | $1.1M |
| Jun 18, 2026 | Carroll Patrick Harrison Officer |
23,726 | $830K |
| Jun 17, 2026 | Becklund Irene Officer |
4,490 | $141K |
| Jun 17, 2026 | Elshenawy Mohamed Officer |
30,040 | $946K |
| Jun 17, 2026 | Chi Michael Officer |
14,027 | $442K |
| Jun 16, 2026 | Becklund Irene Officer |
7,573 | $229K |
| Apr 20, 2026 | Boughton Soleil Officer |
9,463 | $284K |
| Apr 6, 2026 | Oluyemi Okupe Officer |
240,560 | $4.9M |
| Mar 17, 2026 | Boughton Soleil Officer |
4,812 | $119K |
| Mar 17, 2026 | Becklund Irene Officer |
5,529 | $137K |
| Mar 17, 2026 | Chi Michael Officer |
97,289 | $2.4M |
| Feb 27, 2026 | Boughton Soleil Officer |
4,651 | $71K |
| Jan 20, 2026 | Oluyemi Okupe Officer |
27,204 | $829K |
| Dec 22, 2025 | Oluyemi Okupe Officer |
32,160 | $1.1M |
| Dec 17, 2025 | Carroll Patrick Harrison Officer, Director |
10,021 | $368K |
| Dec 17, 2025 | Chi Michael Officer |
13,750 | $505K |
| Dec 17, 2025 | Becklund Irene Officer |
8,411 | $309K |
| Dec 17, 2025 | Autor Deborah M. Officer, Director |
7,054 | $259K |
| Dec 9, 2025 | Perez Garcia Andrea G Director |
2,500 | $98K |
| Nov 24, 2025 | Boughton Soleil Officer |
2,631 | $92K |
Show the other 25 notices
From the Form 144 XML filed with the SEC, since Nov 24, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Sources
Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.
Also
Insider trades: the Form 4s for the sales these plans led to.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/HIMS/export.csv") into a cell.